{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T14:16:47Z","timestamp":1792937807512,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejpn.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T01:59:37Z","timestamp":1693360777000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy"],"prefix":"10.1016","volume":"47","author":[{"given":"Nicola","family":"Specchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Auvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Benvenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-8230","authenticated-orcid":false,"given":"Luca","family":"de Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5015-250X","authenticated-orcid":false,"given":"Katarzyna","family":"Kotulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Sarnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-0139","authenticated-orcid":false,"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejpn.2023.08.005_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib6","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/humu.24454","article-title":"Mosaicism in tuberous sclerosis complex: lowering the threshold for clinical reporting","volume":"43","author":"Ye","year":"2022","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ejpn.2023.08.005_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with No mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.ejpn.2023.08.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104309","article-title":"A\u00a0multistep approach to the genotype-phenotype analysis of Polish patients with tuberous sclerosis complex","volume":"64","author":"B\u0105bol-Pokora","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2023.08.005_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","article-title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","volume":"21","author":"Curatolo","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fneur.2020.00639","article-title":"Autism and epilepsy in patients with tuberous sclerosis complex","volume":"11","author":"Specchio","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4040","article-title":"Presentation and diagnosis of tuberous sclerosis complex in infants","volume":"140","author":"Davis","year":"2017","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ejpn.2023.08.005_bib13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejpn.2014.06.009","article-title":"Epilepsy in newborns with tuberous sclerosis complex","volume":"18","author":"Kotulska","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib15","article-title":"Clinical seizure semiology is subtle and identification of seizures by parents is unreliable in infants with tuberous sclerosis complex","author":"Lynch","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejpn.2023.08.005_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejpn.2018.05.006","article-title":"Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations","volume":"22","author":"Curatolo","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.ejpn.2023.08.005_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the <scp>EPISTOP<\/scp> trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann. Neurol."},{"issue":"10056","key":"10.1016\/j.ejpn.2023.08.005_bib19","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2020.11.003","article-title":"Approach to preventive epilepsy treatment in tuberous sclerosis complex and current clinical practice in 23 countries","volume":"115","author":"S\u0142owi\u0144ska","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1684\/epd.2021.1253","article-title":"Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what","volume":"23","author":"Specchio","year":"2021","journal-title":"Epileptic Disord."},{"issue":"56","key":"10.1016\/j.ejpn.2023.08.005_bib23","doi-asserted-by":"crossref","first-page":"95516","DOI":"10.18632\/oncotarget.20764","article-title":"Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1\/TSC2 biallelic inactivation, and no BRAF mutations","volume":"8","author":"Bongaarts","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14737175.2018.1428562","article-title":"mTOR dysregulation and tuberous sclerosis-related epilepsy","volume":"18","author":"Curatolo","year":"2018","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","article-title":"Roles of mTOR signaling in brain development","volume":"24","author":"Lee","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.ejpn.2023.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58737","article-title":"mTOR signaling regulates the morphology and migration of outer radial glia in developing human cortex","volume":"9","author":"Andrews","year":"2020","journal-title":"Elife"},{"issue":"15","key":"10.1016\/j.ejpn.2023.08.005_bib28","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1523\/JNEUROSCI.1434-18.2020","article-title":"Mechanistic target of rapamycin regulates the oligodendrocyte cytoskeleton during myelination","volume":"40","author":"Musah","year":"2020","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib29","first-page":"521","article-title":"New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives","volume":"235","author":"M\u00fchlebner","year":"2019","journal-title":"J.\u00a0Anat."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib30","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000540","article-title":"Is focal cortical dysplasia\/epilepsy caused by somatic MTOR mutations always a unilateral disorder?","volume":"7","author":"Guerrini","year":"2021","journal-title":"Neurol Genet"},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1535759718822039","article-title":"The space-time continuum of cortical dysplasia","volume":"19","author":"Jansen","year":"2019","journal-title":"Epilepsy Curr."},{"issue":"14","key":"10.1016\/j.ejpn.2023.08.005_bib32","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1523\/JNEUROSCI.2260-18.2019","article-title":"mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia","volume":"39","author":"Nguyen","year":"2019","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejpn.2023.08.005_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fnins.2020.00899","article-title":"Progression of fetal brain lesions in tuberous sclerosis complex","volume":"14","author":"Gelot","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejpn.2023.08.005_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpeds.2021.02.060","article-title":"Fetal brain magnetic resonance imaging findings predict neurodevelopment in children with tuberous sclerosis complex","volume":"233","author":"Hulshof","year":"2021","journal-title":"J.\u00a0Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13023-018-0764-z","article-title":"Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?","volume":"13","author":"S\u0142owi\u0144ska","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00330-022-09036-3","article-title":"The longitudinal evolution of cerebral blood flow in children with tuberous sclerosis assessed by arterial spin labeling magnetic resonance imaging may be related to cognitive performance","volume":"33","author":"Rutten","year":"2023","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib37","article-title":"Tuberous sclerosis complex is associated with a novel human tauopathy","author":"Hwang","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad048","article-title":"Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy","author":"Aronica","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib39","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1038\/s41598-017-06145-8","article-title":"Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment","volume":"7","author":"Mills","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpn.2023.08.005_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fneur.2020.01028","article-title":"Tuberous sclerosis complex as disease model for investigating mTOR-related gliopathy during epileptogenesis","volume":"11","author":"Zimmer","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5698\/1535-7597-13.4.172","article-title":"Interneuron development and epilepsy: early genetic defects cause long-term consequences in seizures and susceptibility","volume":"13","author":"Powell","year":"2013","journal-title":"Epilepsy Curr."},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/nan.12744","article-title":"Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies","volume":"47","author":"Gruber","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","article-title":"Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex","volume":"80","author":"Zhang","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejpn.2023.08.005_bib45","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/ncomms5563","article-title":"Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model","volume":"5","author":"Lozovaya","year":"2014","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejpn.2023.08.005_bib46","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/epi.17396","article-title":"GluN2C selective inhibition is a target to develop new antiepileptic compounds","volume":"63","author":"Gataullina","year":"2022","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajmg.c.31637","article-title":"A\u00a0clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"178","author":"de Vries","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"10.1016\/j.ejpn.2023.08.005_bib48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/dmcn.15307","article-title":"The autism spectrum disorder phenotype in children with tuberous sclerosis complex: a systematic review and meta-analysis","volume":"64","author":"Mitchell","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"issue":"Pt A","key":"10.1016\/j.ejpn.2023.08.005_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib50","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/jcm8060788","article-title":"Early clinical predictors of autism spectrum disorder in infants with tuberous sclerosis complex: results from the EPISTOP study","volume":"8","author":"Moavero","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.22696","article-title":"Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia","volume":"71","author":"Talos","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2015.12.005","article-title":"Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC","author":"Curatolo","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2023.08.005_bib53","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/acn3.51128","article-title":"Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?","volume":"7","author":"Moavero","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/brain\/awaa371","article-title":"Developmental and epileptic encephalopathies: what we do and do not know","volume":"144","author":"Specchio","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2023.08.005_bib56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"14","key":"10.1016\/j.ejpn.2023.08.005_bib57","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0883073817737446","article-title":"Predictors of drug-resistant epilepsy in tuberous sclerosis complex","volume":"32","author":"Jeong","year":"2017","journal-title":"J.\u00a0Child Neurol."},{"issue":"23","key":"10.1016\/j.ejpn.2023.08.005_bib58","first-page":"10","article-title":"Risk factors associated with refractory epilepsy in patients with tuberous sclerosis complex: a systematic review","author":"Miszewska","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib59","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/epi.16379","article-title":"Scalp EEG spikes predict impending epilepsy in TSC infants: a longitudinal observational study","volume":"60","author":"Wu","year":"2019","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.ejpn.2023.08.005_bib60","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","volume":"22","author":"Og\u00f3rek","year":"2020","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/dmcn.15073","article-title":"Evolution of electroencephalogram in infants with tuberous sclerosis complex and neurodevelopmental outcome: a prospective cohort study","volume":"64","author":"De Ridder","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2023.08.005_bib62","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/epi.16892","article-title":"Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes","volume":"62","author":"De Ridder","year":"2021","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib63","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1212\/WNL.0000000000200027","article-title":"Association of early MRI characteristics with subsequent epilepsy and neurodevelopmental outcomes in children with tuberous sclerosis complex","volume":"98","author":"Hulshof","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ejpn.2023.08.005_bib64","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","volume":"22","author":"Og\u00f3rek","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2023.08.005_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582891","article-title":"Prediction of neurodevelopment in infants with tuberous sclerosis complex using early EEG characteristics","volume":"11","author":"De Ridder","year":"2020","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib66","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1212\/WNL.0000000000200027","article-title":"Association of early MRI characteristics with subsequent epilepsy and neurodevelopmental outcomes in children with tuberous sclerosis complex","volume":"98","author":"Hulshof","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib67","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.26015","article-title":"Tuber locations associated with infantile spasms map to a common brain network","volume":"89","author":"Cohen","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17353","article-title":"Epileptic spasms are associated with increased stereo-electroencephalography derived functional connectivity in tuberous sclerosis complex","author":"Neal","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2023.08.005_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2020.07.015","article-title":"Epilepsy risk prediction model for patients with tuberous sclerosis complex","volume":"113","author":"Farach","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.107040","article-title":"Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complex","volume":"188","author":"Zhao","year":"2022","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejpn.2023.08.005_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2020.11.003","article-title":"Approach to preventive epilepsy treatment in tuberous sclerosis complex and current clinical practice in 23 countries","volume":"115","author":"S\u0142owi\u0144ska","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WNO.0000000000000609","article-title":"Vigabatrin: lessons learned from the United States experience","volume":"38","author":"Foroozan","year":"2018","journal-title":"J.\u00a0Neuro Ophthalmol."},{"issue":"10","key":"10.1016\/j.ejpn.2023.08.005_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.28.727","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization","volume":"28","author":"Sehgal","year":"1975","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejpn.2023.08.005_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109203","article-title":"Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice","volume":"218","author":"Koike-Kumagai","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib75","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ncomms2295","article-title":"Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex","volume":"3","author":"Sato","year":"2012","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.ejpn.2023.08.005_bib76","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/hmg\/dds156","article-title":"The differential effects of prenatal and\/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex","volume":"21","author":"Way","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib77","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1038\/s41467-021-23939-7","article-title":"Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss","volume":"12","author":"Amegandjin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpn.2023.08.005_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.704978","article-title":"Antiepileptic effect and safety profile of rapamycin in pediatric patients with tuberous sclerosis complex","volume":"13","author":"Sadowski","year":"2022","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2023.08.005_bib79","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s40263-021-00835-8","article-title":"Pharmacotherapy for seizures in tuberous sclerosis complex","volume":"35","author":"Nabbout","year":"2021","journal-title":"CNS Drugs"},{"issue":"7928","key":"10.1016\/j.ejpn.2023.08.005_bib80","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41586-022-05213-y","article-title":"Brain-restricted mTOR inhibition with binary pharmacology","volume":"609","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.ejpn.2023.08.005_bib81","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","article-title":"Long-term treatment of epilepsy with everolimus in tuberous sclerosis","volume":"87","author":"Krueger","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ejpn.2023.08.005_bib82","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Heal"},{"key":"10.1016\/j.ejpn.2023.08.005_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.630378","article-title":"TuberOus SClerosis registry to increAse disease awareness (TOSCA) post-authorisation safety study of everolimus in patients with tuberous sclerosis complex","volume":"12","author":"Kingswood","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2023.08.005_bib84","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A\u00a0randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib85","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","article-title":"Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): multicentre clinical experience","volume":"22","author":"Krueger","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2023.08.005_bib86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2018.10.005","article-title":"Longitudinal effects of everolimus on white matter diffusion in tuberous sclerosis complex","volume":"90","author":"Peters","year":"2019","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s11689-021-09357-2","article-title":"mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus","volume":"13","author":"Petrasek","year":"2021","journal-title":"J.\u00a0Neurodev. Disord."},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib88","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00381-021-05218-4","article-title":"Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: a case report","volume":"37","author":"Cavalheiro","year":"2021","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"10.1016\/j.ejpn.2023.08.005_bib89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/CPJ.0000000000000514","article-title":"Everolimus for treatment-refractory seizures in TSC","volume":"8","author":"Franz","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"10.1016\/j.ejpn.2023.08.005_bib90","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40265-016-0552-9","article-title":"The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions","volume":"76","author":"Curatolo","year":"2016","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ejpn.2023.08.005_bib91","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2022.2.FOCUS21789","article-title":"The role of neurosurgery in the management of tuberous sclerosis complex-associated epilepsy: a systematic review","volume":"52","author":"Nie","year":"2022","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.ejpn.2023.08.005_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.697467","article-title":"Historical patterns of diagnosis, treatments, and outcome of epilepsy associated with tuberous sclerosis complex: results from TOSCA registry","volume":"12","author":"Nabbout","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2023.08.005_bib93","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/brain\/awz411","article-title":"Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China","volume":"143","author":"Liu","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2023.08.005_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117506","article-title":"Seizure outcome after epilepsy surgery in tuberous sclerosis complex: results and analysis of predictors from a multicenter study","volume":"427","author":"Vannicola","year":"2021","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ejpn.2023.08.005_bib95","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/cjn.2020.185","article-title":"Effect of gene mutation on seizures in surgery for tuberous sclerosis complex","volume":"48","author":"Chivukula","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ejpn.2023.08.005_bib96","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1227\/neu.0000000000002214","article-title":"Epilepsy surgery in young children with tuberous sclerosis complex: a novel hybrid multimodal surgical approach","volume":"92","author":"Ravindra","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejpn.2023.08.005_bib97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.seizure.2022.10.011","article-title":"Satisfaction and seizure outcomes of epilepsy surgery in tuberous sclerosis: a Swedish population-based long-term follow-up study","volume":"103","author":"Pearsson","year":"2022","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.ejpn.2023.08.005_bib98","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00381-019-04255-4","article-title":"\u201cLaser and the Tuber\u201d: thermal dynamic and volumetric factors influencing seizure outcomes in pediatric subjects with tuberous sclerosis undergoing stereoencephalography-directed laser ablation of tubers","volume":"35","author":"Stellon","year":"2019","journal-title":"Child's Nerv. Syst."},{"key":"10.1016\/j.ejpn.2023.08.005_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108431","article-title":"Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex","volume":"126","author":"Tong","year":"2022","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejpn.2023.08.005_bib100","first-page":"1","article-title":"The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis","author":"Hajtovic","year":"2022","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"key":"10.1016\/j.ejpn.2023.08.005_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.863826","article-title":"Ketogenic diet therapy for drug-resistant epilepsy and cognitive impairment in children with tuberous sclerosis complex","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.08.005_bib102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14581\/jer.17008","article-title":"Ketogenic diet for the management of epilepsy associated with tuberous sclerosis complex in children","volume":"7","author":"Park","year":"2017","journal-title":"J\u00a0Epilepsy Res"},{"key":"10.1016\/j.ejpn.2023.08.005_bib103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yebeh.2016.07.034","article-title":"Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex","volume":"63","author":"Fallah","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.ejpn.2023.08.005_bib104","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ejpn.2023.08.005_bib105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0039-1695786","article-title":"Cannabidiol interacts significantly with everolimus-report of a patient with tuberous sclerosis complex","volume":"50","author":"Wiemer-Kruel","year":"2019","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2023.08.005_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2019.11.017","article-title":"Cannabidiol elevates mechanistic target of rapamycin inhibitor levels in patients with tuberous sclerosis complex","volume":"105","author":"Ebrahimi-Fakhari","year":"2020","journal-title":"Pediatr. Neurol."},{"issue":"S1","key":"10.1016\/j.ejpn.2023.08.005_bib107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1684\/epd.2020.1135","article-title":"The proposed mechanisms of action of CBD in epilepsy","volume":"22","author":"Gray","year":"2020","journal-title":"Epileptic Disord."},{"issue":"4","key":"10.1016\/j.ejpn.2023.08.005_bib108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.ejpn.2023.08.005_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/life12122042","article-title":"GABAergic neurotransmission in human tissues is modulated by cannabidiol","volume":"12","author":"Ruffolo","year":"2022","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.ejpn.2023.08.005_bib110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s40265-022-01724-0","article-title":"Ganaxolone: first approval","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.ejpn.2023.08.005_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100715","article-title":"The metformin in tuberous sclerosis (MiTS) study: a randomised double-blind placebo-controlled trial","volume":"32","author":"Amin","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejpn.2023.08.005_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107934","article-title":"New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?","volume":"229","author":"L\u00f6scher","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.ejpn.2023.08.005_bib113","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcma.2018.02.001","article-title":"Trend of seizure remission in patients with tuberous sclerosis complex: a retrospective medical review","volume":"81","author":"Wei","year":"2018","journal-title":"J.\u00a0Chin. Med. Assoc."}],"updated-by":[{"DOI":"10.1016\/j.ejpn.2023.12.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T22:37:02Z","timestamp":1729982222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379823001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":113,"alternative-id":["S1090379823001332"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.08.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}